How to manage transfusion systems in developing countries: The Experience of Eastern and Southern Mediterranean countries

Abstract

Objectives To outline and analyse the national organisation, infrastructure and management of transfusion systems in countries sharing common historical, cultural and economic features and to decipher management trends, in order to potentially benchmark. Background Little is known regarding transfusion systems in Eastern/southern Mediterranean at a time international organisations are calling for the establishment of a safe and sustainable blood system. Materials and Methods Data emanating from eight Arabic‐speaking Eastern/Southern Mediterranean countries who responded to five surveys were collected and tabulated. Results While similarities in terms of supervision by national authorities, authorization of blood centres, quality control and management information system are evident, some significant divergence between these countries do exists. Only Lebanon does not possess a national blood establishment or organisation for blood supply. Blood components are fully government‐subsidised in Algeria and Mauritania. Algeria, Morocco and Tunisia have a blood supply that relies mainly on Voluntary non‐remunerated donors. Plateletpheresis is performed in all countries except Mauritania while plasmapheresis exists only in Algeria and Egypt. Morocco is the sole country outsourcing its plasma for Plasma derived products. Conclusion Despite the various challenges facing these countries, lot of progresses have been made so far in the field of transfusion medicine. Yet, nationally coordinated blood programs overviewed by national regulatory authorities and actively supported by local governments are still needed to ensure the optimum level of blood safety.

Quality Improvement in a small‐scale Caribbean Blood Bank: the value of long‐term collaboration and stepwise process approach

“…This results in transparent cost determination per labile blood product unit ensuring adequate resources. This model is unique for the region and is in effect in several countries in Europe and the Middle East [10,15,16].…”

Transfusion Medicine Practice During COVID-19 Pandemic: Potential Pitfalls and Solutions for Provision of Blood Products

“…Pakistan lacks a centralized system or coordinated blood transfusion service leading to wide heterogeneity in terms of availability of blood components, the sufficiency of blood supply, presence and educational level of medical directors and technologists as well as infrastructure and other resources. 12 While the blood supply for patients with hemoglobinopathies come from volunteer donors, most rural and small city clinics and hospital rely on whole blood donation from patients' relatives and friends in cases of surgeries or other procedures which raises significant questions about the quality and safety of blood components. It is, therefore, critical that hospital systems providing care at various levels, collaborate to achieve the following: 1.…”

A Study of Blood Transfusion in Pediatric Patients at a Teaching Hospital, Aden, Yemen

“…8 In the Middle Eastern Region which is consisting of heterogeneous countries with different levels of development, the demand for blood transfusion is on the rise as a result of increased accessibility to more advanced medical and surgical procedures, expansion of aging population, and in children there is high prevalence of transfusion dependent β-thalassemia and sickle cell disease. 9 Beside the efforts for strengthening the infrastructure and testing for transfusion transmissible infections, regular documented clinical review plays a vital role in monitoring and evaluation of clinical transfusion practices, optimization of blood use and consistent adherence to guidelines and standard operating procedures. 10 Children are the main users of blood, and in resourcelimited-settings they account for a high proportion of blood usage (16-67%), compared to about 5% reported from developed countries.…”